BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28416102)

  • 1. Synthesis, biochemical evaluation, and molecular modeling studies of aryl and arylalkyl di-n-butyl phosphates, effective butyrylcholinesterase inhibitors.
    Nakayama K; Schwans JP; Sorin EJ; Tran T; Gonzalez J; Arteaga E; McCoy S; Alvarado W
    Bioorg Med Chem; 2017 Jun; 25(12):3171-3181. PubMed ID: 28416102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biochemical evaluation, and molecular modeling of organophosphate-coumarin hybrids as potent and selective butyrylcholinesterase inhibitors.
    Macklin LJ; Schwans JP
    Bioorg Med Chem Lett; 2020 Jul; 30(13):127213. PubMed ID: 32381396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines.
    Kumar RS; Almansour AI; Arumugam N; Althomili DMQ; Altaf M; Basiri A; D K; Sai Manohar T; S V
    Bioorg Chem; 2018 Apr; 77():263-268. PubMed ID: 29421701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
    Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA
    Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient synthesis of novel dialkyl-3-cyanopropylphosphate derivatives and evaluation of their anticholinesterase activity.
    Aouani I; Sellami B; Lahbib K; Cavalier JF; Touil S
    Bioorg Chem; 2017 Jun; 72():301-307. PubMed ID: 28500956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialkyl phenyl phosphates as novel selective inhibitors of butyrylcholinesterase.
    Law KS; Acey RA; Smith CR; Benton DA; Soroushian S; Eckenrod B; Stedman R; Kantardjieff KA; Nakayama K
    Biochem Biophys Res Commun; 2007 Apr; 355(2):371-8. PubMed ID: 17307152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
    Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
    Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
    Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
    Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and comparison of the biological activity of monocyclic phosphonate, difluorophosphonate and phosphate analogs of the natural AChE inhibitor cyclophostin.
    Martin BP; Vasilieva E; Dupureur CM; Spilling CD
    Bioorg Med Chem; 2015 Dec; 23(24):7529-34. PubMed ID: 26585276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of difunctionalized 4-hydroxybenzaldehyde derivatives as novel cholinesterase inhibitors.
    Yu L; Cao R; Yi W; Yan Q; Chen Z; Ma L; Song H
    Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1216-20. PubMed ID: 20823602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.
    Razavi SF; Khoobi M; Nadri H; Sakhteman A; Moradi A; Emami S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2013 Jun; 64():252-9. PubMed ID: 23644208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel carbamate derivatives as selective butyrylcholinesterase inhibitors.
    Bajda M; Łątka K; Hebda M; Jończyk J; Malawska B
    Bioorg Chem; 2018 Aug; 78():29-38. PubMed ID: 29529519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro evaluation and in-silico studies applied on newly synthesized amide derivatives of N-phthaloylglycine as Butyrylcholinesterase (BChE) inhibitors.
    Begum S; Nizami SS; Mahmood U; Masood S; Iftikhar S; Saied S
    Comput Biol Chem; 2018 Jun; 74():212-217. PubMed ID: 29653432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors.
    Gao CZ; Dong W; Cui ZW; Yuan Q; Hu XM; Wu QM; Han X; Xu Y; Min ZL
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):150-162. PubMed ID: 30427217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
    Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 3-thiazolocoumarinyl Schiff-base derivatives as cholinesterase inhibitors.
    Raza R; Saeed A; Arif M; Mahmood S; Muddassar M; Raza A; Iqbal J
    Chem Biol Drug Des; 2012 Oct; 80(4):605-15. PubMed ID: 22726458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkynyl and β-ketophosphonates: Selective and potent butyrylcholinesterase inhibitors.
    Cavallaro V; Moglie YF; Murray AP; Radivoy GE
    Bioorg Chem; 2018 Apr; 77():420-428. PubMed ID: 29427857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
    Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
    Darras FH; Kling B; Sawatzky E; Heilmann J; Decker M
    Bioorg Med Chem; 2014 Sep; 22(17):5020-34. PubMed ID: 25059502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation and docking studies of 2,3-dihydroquinazolin-4(1H)-one derivatives as inhibitors of cholinesterases.
    Sarfraz M; Sultana N; Rashid U; Akram MS; Sadiq A; Tariq MI
    Bioorg Chem; 2017 Feb; 70():237-244. PubMed ID: 28126287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.